참고문헌
- von Minckwitz G, Untch M, Blohmer JU, et al. Definition and impact of pathologic complete response on prognosis after neoad-juvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012;30:1796-804. https://doi.org/10.1200/JCO.2011.38.8595
- START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331-41. https://doi.org/10.1016/S1470-2045(08)70077-9
- START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371:1098-107. https://doi.org/10.1016/S0140-6736(08)60348-7
- Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013;14:1086-94. https://doi.org/10.1016/S1470-2045(13)70386-3
- Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757-70. https://doi.org/10.1016/S0140-6736(00)02263-7
- Wang SL, Fang H, Song YW, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol 2019;20:352-60. https://doi.org/10.1016/s1470-2045(18)30813-1
- Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-20. https://doi.org/10.1056/NEJMoa0906260
- Khan AJ, Poppe MM, Goyal S, et al. Hypofractionated postmastectomy radiation therapy is safe and effective: first results from a prospective phase II trial. J Clin Oncol 2017;35:2037-43. https://doi.org/10.1200/JCO.2016.70.7158
- Yadav BS, Sharma SC, Ghoshal S, Kapoor RK, Kumar N. Postmastectomy internal mammary node radiation in women with breast cancer: a long-term follow-up study. J Radiother Pract 2015;14:385-93. https://doi.org/10.1017/S1460396915000278
- Yadav BS, Sharma SC, Singh R, Singh G. Patterns of relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy followed by surgery and radiotherapy. J Cancer Res Ther 2007;3:75-80. https://doi.org/10.4103/0973-1482.34683
- Yadav BS, Sharma SC, Singh R, Singh G, Kumar V. Postmastectomy radiation and survival in patients with breast cancer. J Cancer Res Ther 2007;3:218-24. https://doi.org/10.4103/0973-1482.38997
- Yadav BS, Sharma SC, Patel FD, Bose SM, Ghoshal S, Kapoor RK. Therapeutic benefit of radiotherapy after surgery in patients with T1-T2 breast tumour. J Radiother Pract 2010;9:33-40. https://doi.org/10.1017/S1460396909990124
- Yadav BS, Sharma SC, George P, Bansal A. Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: is there a benefit? J Cancer Res Ther 2014;10:279-83. https://doi.org/10.4103/0973-1482.136560
- Van Parijs H, Miedema G, Vinh-Hung V, et al. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol 2012;7:80. https://doi.org/10.1186/1748-717X-7-80
- Pinitpatcharalert A, Chitapanarux I, Euathrongchit J, Tharavichitkul E, Sukthomya V, Lorvidhaya V. A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. J Med Assoc Thai 2011;94 Suppl 2:S94-102.
- Poortmans P, Kouloulias V, van Tienhoven G, et al. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works. Strahlenther Onkol 2006;182:576-82. https://doi.org/10.1007/s00066-006-1629-2
- Koukourakis MI, Panteliadou M, Abatzoglou IM, Sismanidou K, Sivridis E, Giatromanolaki A. Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection. Int J Radiat Oncol Biol Phys 2013;85:e7-13. https://doi.org/10.1016/j.ijrobp.2012.08.017
- Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 2015;114:3-10. https://doi.org/10.1016/j.radonc.2014.11.030
- Radiation Therapy Oncology Group. Breast cancer atlas for radiation therapy planning: consensus definitions [Internet]. Philadelphia, PA: Radiation Therapy Oncology Group; 2016 [cited 2020 May 10]. Available from: https://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx.
- Donker M, Slaets L, van Tienhoven G, Rutgers EJ. Axillary lymph node dissection versus axillary radiotherapy in patients with a positive sentinel node: the AMAROS trial. Ned Tijdschr Geneeskd 2015;159:A9302.
- Shah C, Wilkinson JB, Baschnagel A, et al. Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. Int J Radiat Oncol Biol Phys 2012;83:1095-100. https://doi.org/10.1016/j.ijrobp.2011.09.058
- Ugur S, Arici C, Yaprak M, et al. Risk factors of breast cancer-related lymphedema. Lymphat Res Biol 2013;11:72-5. https://doi.org/10.1089/lrb.2013.0004
- Jung SY, Shin KH, Kim M, et al. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients. Breast Cancer Res Treat 2014;148:91-8. https://doi.org/10.1007/s10549-014-3137-x
- Chandra RA, Miller CL, Skolny MN, et al. Radiation therapy risk factors for development of lymphedema in patients treated with regional lymph node irradiation for breast cancer. Int J Radiat Oncol Biol Phys 2015;91:760-4. https://doi.org/10.1016/j.ijrobp.2014.12.029
- Yarnold J, Bentzen SM, Coles C, Haviland J. Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011;79:1-9. https://doi.org/10.1016/j.ijrobp.2010.08.035
- Whelan TJ, Olivotto I, Ackerman I, et al. NCIC-CTG MA. 20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 2011;29(18_suppl):LBA1003.
- Badiyan SN, Shah C, Arthur D, et al. Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies. Radiother Oncol 2014;110:39-44. https://doi.org/10.1016/j.radonc.2013.12.006
- Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005;75:9-17. https://doi.org/10.1016/j.radonc.2005.01.005
- Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006;7:467-71. https://doi.org/10.1016/S1470-2045(06)70699-4
- Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor RK. Second primary in the contralateral breast after treatment of breast cancer. Radiother Oncol 2008;86:171-6. https://doi.org/10.1016/j.radonc.2007.10.002
- Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor R, Kumar R. Nonbreast second malignancies after treatment of primary breast cancer. Int J Radiat Oncol Biol Phys 2009;73:1489-92. https://doi.org/10.1016/j.ijrobp.2008.07.004
- Yadav BS, Sharma SC, Patel FD, Rai B, Ghoshal S. Gynecological Cancer as a Second Malignancy in Patients With Breast Cancer. Int J Gynecol Cancer 2017;27:1298-304. https://doi.org/10.1097/igc.0000000000000993
- International Atomic Energy Agency. Planning national radiotherapy services: a practical tool. Vienna, Austria: International Atomic Energy Agency; 2010.
- Hahn C, Kavanagh B, Bhatnagar A, et al. Choosing wisely: the American Society for Radiation Oncology's top 5 list. Pract Radiat Oncol 2014;4:349-55. https://doi.org/10.1016/j.prro.2014.06.003
- Smith BD, Bellon JR, Blitzblau R, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol 2018;8:145-52. https://doi.org/10.1016/j.prro.2018.01.012